Will Acelity go public again?

Privately held Acelity may go public again, according to news reports this week. London-based Apax Partners and a pair of Canadian pension funds acquired wound-care company Kinetic Concepts Inc. (now Acelity) for $6.1 billion in a leveraged buyout in 2011.  Apax is now mulling an initial public offering for Acelity by mid-2019, Bloomberg and the San Antonio Express-news reported. Bloomberg cited unnamed sources with knowledge of the possible IPO, the Express-News report said. Apax has begun discussing a potential listing with advisers, the news outlets said. Sources told Bloomberg that an IPO could value Acelity at $5 billion. “While we are always reviewing the strategic options available to our company, our policy is not to comment on market speculation and rumors,” Acelity spokesman Maggie Fairchild told MassDevice in an email. Apax also declined comment. In 2016, Acelity called off an initial public offering that could have fetched as much as $1 billion, citing market conditions. Earlier this year, Acelity agreed to sell its Systagenix facility in Gargrave, England, to Scapa Healthcare and inked a deal to buy Crawford Healthcare. Then-KCI had acquired Systagenix for $485 million in 2013. The company united Systagenix, LifeCell and KCI under the Acelity brand in 2014 and sold LifeCell to Allergan for $2.9 billion in 2016. Jim Leininger, M.D., an accident and emergency physician, founded KCI in 1976 to manufacture a critical care bed. KCI rais...
Source: Mass Device - Category: Medical Devices Authors: Tags: Blog Business/Financial News Initial Public Offering (IPO) News Well Wall Street Beat Wound Care Acelity Apax Partners kci Source Type: news

Related Links:

Condition:   Influenza Intervention:   Biological: Quadrivalent inactivated influenza vaccine (IIV) Sponsors:   Stanford University;   National Institutes of Health (NIH);   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
ConclusionsThis study indicates that a substantial proportion of subjects with OA experience severe asthma and identifies potentially modifiable risk factors for severe OA that should be targeted in order to reduce the adverse impacts of the disease.
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research
AbstractBackgroundIn wheat-dependent exercise-induced anaphylaxis (WDEIA), cofactors such as exercise, acetylsalicylic acid (ASA), alcohol or unfavorable climatic conditions are required to elicit a reaction to wheat products. The mechanism of action of these cofactors is unknown, but an increase of gliadin absorption has been speculated. Our objectives were to study gliadin absorption with and without cofactors and to correlate plasma gliadin levels with factors influencing protein absorption in healthy volunteers.MethodsTwelve healthy probands (six males, six females; aged 20 –56 years) ingested 32 g of g...
Source: Clinical and Translational Allergy - Category: Allergy & Immunology Source Type: research
(MedPage Today) -- New evidence also presented on breastfeeding and development of atopic disease, asthma
Source: MedPage Today Allergy - Category: Allergy & Immunology Source Type: news
Publication date: Available online 23 March 2019Source: Journal of Food Composition and AnalysisAuthor(s): Katsunari Ippoushi, Yoshimi Tanaka, Manabu Wakagi, Naoto Hashimoto, Yuko Takano-IshikawaAbstractPru p 1 and Pru p 3 are proteins found in peach (Prunus persica (L.) Batsch), and they are members of the pathogenesis-related protein 10 (PR-10) and non-specific lipid transfer protein (nsLTP) families, respectively. They are the main allergens of peach. In this paper, we describe a quantitative method for these proteins based on protein absolute quantification with liquid chromatography–tandem mass spectrometry, and...
Source: Journal of Food Composition and Analysis - Category: Food Science Source Type: research
Giving thyroid hormone replacement before conception didn't prevent miscarriages or other adverse pregnancy outcomes in euthyroid women with thyroid peroxidase antibodies, shows the TABLET trial.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Diabetes & Endocrinology News Source Type: news
This study aimed to investigate whether subcutaneous immunotherapy (SCIT) with Fagales pollen-containing extracts can improve the clinical symptoms of OAS in Korea. In total, 56 OAS patients were included: 19 subjects treated with SCIT, which included Fagales pollen extracts, and 37 not treated with immunotherapy (IT). We reviewed the patients' medical records and administered a telephone questionnaire at one point to assess baseline OAS features and changes in the patients' OAS and allergic rhinoconjunctivitis (ARC) symptoms after treatment. Only 12 patients who received SCIT and 15 patients that did not receive SCIT coul...
Source: Yonsei Medical Journal - Category: Universities & Medical Training Authors: Tags: Yonsei Med J Source Type: research
ConclusionsWe designed a highly specific 13 ‐item instrument for identifying SPT‐negative patients. It may be used in middle income countries where allergy testing is expensive, not reimbursed or few allergy clinics are available. We think that our idea is interesting, that needs further research.
Source: The Clinical Respiratory Journal - Category: Respiratory Medicine Authors: Tags: ORIGINAL ARTICLE Source Type: research
Publication date: Available online 23 March 2019Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Pooja Mehta, Zhaoxing Pan, Glenn T. Furuta, Bethany M. Kwan
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research
Publication date: Available online 23 March 2019Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Michele N. Pham, Michael Pistiner, Julie Wang
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research
More News: Accidents | Allergy | Blogging | Canada Health | Emergency Medicine | Pensions